Smart Insulin Pen Market by Current Trends, SWOT and Regional Analysis Forecast till 2028 | Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk

A smart insulin pen is a Bluetooth-enabled wireless device with an intuitive smartphone app that can help people with diabetes to manage insulin delivery. Insulin is an important compound for the management of diabetes, especially for type 2 diabetes. Smart insulin pens track critical data such as date, time, and the amount of insulin to offer safe/efficient diabetes management. The major factor driving the growth of the smart insulin pen market is the increasing prevalence of diabetes around the world. According the International Diabetes Federation (IDF), in 2019, around 463 million adults (aged 20 to 79 years) were living with diabetes, and this number is expected to reach 700 million by 2045.

Key participants for business development are Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, and Companion Medical Inc.

Request a sample copy of help grow your business @
https://www.coherentmarketinsights.com/insight/request-sample/3436

This in turn is expected to increase the demand for smart insulin pens, driving the growth of the smart insulin pens market. Prevalence has been rising more rapidly in low- and middle-income countries than in high-income countries. According to the World Health Organization (WHO), in 2019, an estimated 1.5 million deaths were directly caused by diabetes. Moreover, the proportion of people with type 2 diabetes is also increasing rapidly worldwide. Generally, one unit of insulin is needed to drop the blood glucose by 50 mg/dl. This drop range from 30-100 mg/dl or more, depending on individual insulin sensitivities, and other circumstances.

In North America, diabetes cases have increased in the past few years. According to the Centers for Disease Control and Prevention (CDC), in 2018, around 34.2 million people, or 10.5% of the U.S. population, have diabetes, while around 26.8 million people (10.2% of the population) had diagnosed diabetes. Thus, there is an increasing demand for smart insulin pen in this region. In November 2020, Medtronic launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA (the Food and Drug Administration) approved smart insulin pen on the market for people on multiple daily injections (MDI). This in turn is expected to accelerate the growth of the smart insulin pen market in North America.

Market players are focused on increasing the availability of Bluetooth-connected smart insulin pens, including both Android and Apple operating systems. Moreover, the treatment for type-2 diabetes is expected to witness a significant incline, thus generating demand in the segment. However, the availability of substitute products, such as smart insulin patches, and the lack of adoption of smart insulin pen, especially in emerging economies, are some of the major factors restraining the growth of the smart insulin pen market.

Reasons to Purchase this Report

Current and future of global Smart Insulin Pen market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3436

Years Considered to Estimate the Smart Insulin Pen Market Size:

History Year: 2016-2020
Base Year: 2020
Forecast Year: 2021-2028

Important Features and Key Highlights of the Market:-

• Detailed overview of market application and advantages.
• Understand the technologies support, Solution, Services. Understand the evaluation of dynamic growth.
• The in-depth market information of competitors, revenue, and cost structure.
• Strategies of key players, the competitive landscape.
• Historical data, current trend, and market volume and value.
• Industry restrains drivers and opportunities.
• product Development and offerings Key insights.
• Potential Application covers extensive analysis of emerging trends

Download PDF Brochure of help grow your business @
https://www.coherentmarketinsights.com/insight/request-pdf/3436 

The post Smart Insulin Pen Market by Current Trends, SWOT and Regional Analysis Forecast till 2028 | Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk appeared first on Gatorledger.

A smart insulin pen is a Bluetooth-enabled wireless device with an intuitive smartphone app that can help people with diabetes to manage insulin delivery. Insulin is an important compound for the management of diabetes, especially for type 2 diabetes. Smart insulin pens track critical data such as date, time, and the amount of insulin to offer safe/efficient diabetes management. The major factor driving the growth of the smart insulin pen market is the increasing prevalence of diabetes around the world. According the International Diabetes Federation (IDF), in 2019, around 463 million adults (aged 20 to 79 years) were living with diabetes, and this number is expected to reach 700 million by 2045.

Key participants for business development are Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, and Companion Medical Inc.

Request a sample copy of help grow your business @
https://www.coherentmarketinsights.com/insight/request-sample/3436

This in turn is expected to increase the demand for smart insulin pens, driving the growth of the smart insulin pens market. Prevalence has been rising more rapidly in low- and middle-income countries than in high-income countries. According to the World Health Organization (WHO), in 2019, an estimated 1.5 million deaths were directly caused by diabetes. Moreover, the proportion of people with type 2 diabetes is also increasing rapidly worldwide. Generally, one unit of insulin is needed to drop the blood glucose by 50 mg/dl. This drop range from 30-100 mg/dl or more, depending on individual insulin sensitivities, and other circumstances.

In North America, diabetes cases have increased in the past few years. According to the Centers for Disease Control and Prevention (CDC), in 2018, around 34.2 million people, or 10.5% of the U.S. population, have diabetes, while around 26.8 million people (10.2% of the population) had diagnosed diabetes. Thus, there is an increasing demand for smart insulin pen in this region. In November 2020, Medtronic launched InPen integrated with real-time Guardian Connect CGM data. InPen is the first and only FDA (the Food and Drug Administration) approved smart insulin pen on the market for people on multiple daily injections (MDI). This in turn is expected to accelerate the growth of the smart insulin pen market in North America.

Market players are focused on increasing the availability of Bluetooth-connected smart insulin pens, including both Android and Apple operating systems. Moreover, the treatment for type-2 diabetes is expected to witness a significant incline, thus generating demand in the segment. However, the availability of substitute products, such as smart insulin patches, and the lack of adoption of smart insulin pen, especially in emerging economies, are some of the major factors restraining the growth of the smart insulin pen market.

Reasons to Purchase this Report

Current and future of global Smart Insulin Pen market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3436

Years Considered to Estimate the Smart Insulin Pen Market Size:

History Year: 2016-2020
Base Year: 2020
Forecast Year: 2021-2028

Important Features and Key Highlights of the Market:-

• Detailed overview of market application and advantages.
• Understand the technologies support, Solution, Services. Understand the evaluation of dynamic growth.
• The in-depth market information of competitors, revenue, and cost structure.
• Strategies of key players, the competitive landscape.
• Historical data, current trend, and market volume and value.
• Industry restrains drivers and opportunities.
• product Development and offerings Key insights.
• Potential Application covers extensive analysis of emerging trends

Download PDF Brochure of help grow your business @
https://www.coherentmarketinsights.com/insight/request-pdf/3436 

The post Smart Insulin Pen Market by Current Trends, SWOT and Regional Analysis Forecast till 2028 | Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk appeared first on Gatorledger.